Dr. Kofi Clarke, MD

Dr. Clarke practices at Pshmg Briarcrest (Diabetes & Weight) - HOPD in Hershey, Pennsylvania.

Dr. Clarke's NPI, 1841254851, was assigned on April 14, 2006. Dr. Clarke holds Pennsylvania license MD060406L.

Dr. Clarke's primary practice is Pshmg Briarcrest (Diabetes & Weight) - HOPD, at 905 W Governor Rd, Hershey, PA 17033.

Dr. Clarke's primary practice is Pshmg Briarcrest (Diabetes & Weight) - HOPD in Hershey, Pennsylvania. Dr. Clarke is also affiliated with Penn State Health Milton S. Hershey Medical Center. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Clarke to 2 more hospitals, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clarke practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Clarke's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Clarke is licensed in Pennsylvania.

CMS data shows 202 Medicare services from Dr. Clarke across 8 procedure codes in 2024, for 209 Medicare patients. Medicare paid $21,741 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 209 Medicare patients who saw Dr. Clarke in 2024. The largest group is 65 to 74, with 107 patients. 73% of them have high cholesterol, and 72% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clarke's median patient age at 61, with 50% women.

In 2024, Dr. Clarke wrote 440 Medicare Part D claims for 189 patients. 52% of them were for generic drugs. CMS names the drug for 337 of them, across 10 drugs with 11 or more claims each, at $1,551,909 in total drug cost. In 2023, CMS named 220 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Clarke for performance year 2024, reported as part of a group. Dr. Clarke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Clarke, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 69 papers to Dr. Clarke, published from 2010 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Inflammatory Bowel Diseases, Colitis, Ulcerative and Crohn Disease. Dr. Clarke has published most often in Ann Gastroenterol. Dr. Clarke's most frequent co-authors are Emmanuelle Depayre Williams, MD, Matthew D. Coates, MD, PhD and Andrew Tinsley, MD.

CMS Open Payments shows 435 general payments to Dr. Clarke from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Janssen Pharmaceuticals, Inc paid the most, $244,462.